GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PainReform Ltd (NAS:PRFX) » Definitions » Other Current Receivables

PainReform (PainReform) Other Current Receivables : $0.00 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is PainReform Other Current Receivables?

PainReform's Other Current Receivables for the quarter that ended in Mar. 2024 was $0.00 Mil.

PainReform's annual Other Current Receivables declined from Dec. 2021 ($0.22 Mil) to Dec. 2022 ($0.06 Mil) and declined from Dec. 2022 ($0.06 Mil) to Dec. 2023 ($0.05 Mil).


PainReform Other Current Receivables Historical Data

The historical data trend for PainReform's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PainReform Other Current Receivables Chart

PainReform Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Receivables
Get a 7-Day Free Trial 0.02 0.05 0.22 0.06 0.05

PainReform Quarterly Data
Dec18 Jun19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.05 -

PainReform Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


PainReform Other Current Receivables Related Terms

Thank you for viewing the detailed overview of PainReform's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


PainReform (PainReform) Business Description

Traded in Other Exchanges
N/A
Address
65 Yigal Alon Street, Tel Aviv, ISR, 6744316
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.